UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. )*
ALLOS THERAPEUTICS, INC.
(Name of Issuer)
Common Stock, Par Value $0.001
(Title of Class of Securities)
019777101
(CUSIP Number)
August 7, 2009
(Date of Event which Requires Filing
of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 9
----------------------- --------------------
CUSIP No. 019777101 13G Page 2 of 9 Pages
----------------------- --------------------
---------- ---------------------------------------------------------------------
1 NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
S.A.C. Capital Advisors, L.P.
---------- ---------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [X]
---------- ---------------------------------------------------------------------
3 SEC USE ONLY
---------- ---------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------- ----- ----------------------------------------------------
5 SOLE VOTING POWER
0
NUMBER OF ----- ----------------------------------------------------
SHARES 6 SHARED VOTING POWER
BENEFICIALLY
OWNED 2,335,000 (see Item 4)
BY ----- ----------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING
PERSON 0
WITH: ----- ----------------------------------------------------
8 SHARED DISPOSITIVE POWER
2,335,000 (see Item 4)
---------- ---------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,335,000 (see Item 4)
---------- ---------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
[ ]
---------- ---------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
2.6% (see Item 4)
---------- ---------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
PN
---------- ---------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT
Page 2 of 9
|
----------------------- --------------------
CUSIP No. 019777101 13G Page 3 of 9 Pages
----------------------- --------------------
---------- ---------------------------------------------------------------------
1 NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
S.A.C. Capital Advisors, Inc.
---------- ---------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [X]
---------- ---------------------------------------------------------------------
3 SEC USE ONLY
---------- ---------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------- ----- ----------------------------------------------------
5 SOLE VOTING POWER
0
NUMBER OF ----- ----------------------------------------------------
SHARES 6 SHARED VOTING POWER
BENEFICIALLY
OWNED 2,335,000 (see Item 4)
BY ----- ----------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING
PERSON 0
WITH: ----- ----------------------------------------------------
8 SHARED DISPOSITIVE POWER
2,335,000 (see Item 4)
---------- ---------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,335,000 (see Item 4)
---------- ---------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
[ ]
---------- ---------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
2.6% (see Item 4)
---------- ---------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
CO
---------- ---------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT
Page 3 of 9
|
----------------------- --------------------
CUSIP No. 019777101 13G Page 4 of 9 Pages
----------------------- --------------------
---------- ---------------------------------------------------------------------
1 NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
CR Intrinsic Investors, LLC
---------- ---------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [X]
---------- ---------------------------------------------------------------------
3 SEC USE ONLY
---------- ---------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------- ----- ----------------------------------------------------
5 SOLE VOTING POWER
0
NUMBER OF ----- ----------------------------------------------------
SHARES 6 SHARED VOTING POWER
BENEFICIALLY
OWNED 2,945,370 (see Item 4)
BY ----- ----------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING
PERSON 0
WITH: ----- ----------------------------------------------------
8 SHARED DISPOSITIVE POWER
2,945,370 (see Item 4)
---------- ---------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,945,370 (see Item 4)
---------- ---------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
[ ]
---------- ---------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
3.3% (see Item 4)
---------- ---------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
OO
---------- ---------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT
Page 4 of 9
|
----------------------- --------------------
CUSIP No. 019777101 13G Page 5 of 9 Pages
----------------------- --------------------
---------- ---------------------------------------------------------------------
1 NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Steven A. Cohen
---------- ---------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [X]
---------- ---------------------------------------------------------------------
3 SEC USE ONLY
---------- ---------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------- ----- ----------------------------------------------------
5 SOLE VOTING POWER
0
NUMBER OF ----- ----------------------------------------------------
SHARES 6 SHARED VOTING POWER
BENEFICIALLY
OWNED 5,280,370 (see Item 4)
BY ----- ----------------------------------------------------
EACH 7 SOLE DISPOSITIVE POWER
REPORTING
PERSON 0
WITH: ----- ----------------------------------------------------
8 SHARED DISPOSITIVE POWER
5,280,370 (see Item 4)
---------- ---------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,280,370 (see Item 4)
---------- ---------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
[ ]
---------- ---------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
5.9% (see Item 4)
---------- ---------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
---------- ---------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT
Page 5 of 9
|
Item 1(a) Name of Issuer:
Allos Therapeutics, Inc.
Item 1(b) Address of Issuer's Principal Executive Offices:
11080 CirclePoint Road, Suite 200, Westminster, Colorado
80020
Item 2(a) Name of Person Filing:
This statement is filed by: (i) S.A.C. Capital Advisors,
L.P. ("SAC Capital Advisors LP") with respect to shares of
Common Stock, par value $0.001 (the "Shares") of the Issuer
beneficially owned by S.A.C. Capital Associates, LLC ("SAC
Capital Associates"); (ii) S.A.C. Capital Advisors, Inc.
("SAC Capital Advisors Inc.") with respect to Shares
beneficially owned by SAC Capital Advisors LP and SAC
Capital Associates; (iii) CR Intrinsic Investors, LLC ("CR
Intrinsic Investors") with respect to Shares beneficially
owned by CR Intrinsic Investments, LLC ("CR Intrinsic
Investments"); and (iv) Steven A. Cohen with respect to
Shares beneficially owned by SAC Capital Advisors LP, SAC
Capital Advisors Inc., SAC Capital Associates, CR Intrinsic
Investors and CR Intrinsic Investments.
SAC Capital Advisors LP, SAC Capital Advisors Inc., CR
Intrinsic Investors and Steven A. Cohen have entered into a
Joint Filing Agreement, a copy of which is filed with this
Schedule 13G as Exhibit 99.1, pursuant to which they have
agreed to file this Schedule 13G jointly in accordance with
the provisions of Rule 13d-1(k) of the Act.
Item 2(b) Address or Principal Business Office:
The address of the principal business office of SAC Capital
Advisors LP, SAC Capital Advisors Inc., CR Intrinsic
Investors and Mr. Cohen is 72 Cummings Point Road, Stamford,
Connecticut 06902.
Item 2(c) Citizenship:
SAC Capital Advisors LP is a Delaware limited partnership.
SAC Capital Advisors Inc. is a Delaware corporation. CR
Intrinsic Investors is a Delaware limited liability company.
Mr. Cohen is a United States citizen.
Item 2(d) Title of Class of Securities:
Common Stock, par value $0.001
Page 6 of 9
Item 2(e) CUSIP Number:
019777101
Item 3 Not Applicable
Item 4 Ownership:
The percentages used herein are calculated based upon the
Shares issued and outstanding as of July 31, 2009 as
reported on the Issuer's quarterly report on Form 10-Q filed
with the Securities and Exchange Commission by the Issuer
for the quarterly period ended June 30, 2009.
As of the close of business on August 13, 2009:
1. S.A.C. Capital Advisors, L.P.
(a) Amount beneficially owned: 2,335,000
(b) Percent of class: 2.6%
(c)(i) Sole power to vote or direct the vote: -0-
(ii) Shared power to vote or direct the vote: 2,335,000
(iii) Sole power to dispose or direct the disposition: -0-
(iv) Shared power to dispose or direct the disposition:
2,335,000
2. S.A.C. Capital Advisors, Inc.
(a) Amount beneficially owned: 2,335,000
(b) Percent of class: 2.6%
(c)(i) Sole power to vote or direct the vote: -0-
(ii) Shared power to vote or direct the vote: 2,335,000
(iii) Sole power to dispose or direct the disposition: -0-
(iv) Shared power to dispose or direct the disposition:
2,335,000
3. CR Intrinsic Investors, LLC
(a) Amount beneficially owned: 2,945,370
(b) Percent of class: 3.3%
(c)(i) Sole power to vote or direct the vote: -0-
(ii) Shared power to vote or direct the vote: 2,945,370
(iii) Sole power to dispose or direct the disposition: -0-
(iv) Shared power to dispose or direct the disposition:
2,945,370
4. Steven A. Cohen
(a) Amount beneficially owned: 5,280,370
(b) Percent of class: 5.9%
(c)(i) Sole power to vote or direct the vote: -0-
(ii) Shared power to vote or direct the vote: 5,280,370
(iii) Sole power to dispose or direct the disposition: -0-
(iv) Shared power to dispose or direct the disposition:
5,280,370
SAC Capital Advisors LP, SAC Capital Advisors Inc., CR
Intrinsic Investors and Mr. Cohen own directly no Shares.
Pursuant to an investment management agreement, SAC Capital
Advisors LP maintains investment and voting power with
respect to the securities held by SAC Capital Associates.
SAC Capital Advisors Inc. is the general partner of
Page 7 of 9
SAC Capital Advisors LP. Pursuant to an investment
management agreement, CR Intrinsic Investors maintains
investment and voting power with respect to the securities
held by CR Intrinsic Investments. Mr. Cohen controls each of
SAC Capital Advisors Inc. and CR Intrinsic Investors. By
reason of the provisions of Rule 13d-3 of the Securities
Exchange Act of 1934, as amended, each of (i) SAC Capital
Advisors LP, SAC Capital Advisors Inc. and Mr. Cohen may be
deemed to beneficially own 2,335,000 Shares (constituting
approximately 2.6% of the Shares outstanding) and (ii) CR
Intrinsic Investors and Mr. Cohen may be deemed to
beneficially own 2,945,370 Shares (constituting
approximately 3.3% of the Shares outstanding). Each of SAC
Capital Advisors LP, SAC Capital Advisors Inc., CR Intrinsic
Investors and Mr. Cohen disclaims beneficial ownership of
any of the securities covered by this statement.
Item 5 Ownership of Five Percent or Less of a Class:
If this statement is being filed to report the fact that as
of the date hereof the reporting person has ceased to be the
beneficial owner of more than five percent of the class of
securities, check the following. [ ]
Item 6 Ownership of More than Five Percent on Behalf of Another
Person:
Not Applicable
Item 7 Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on By the Parent
Holding Company:
Not Applicable
Item 8 Identification and Classification of Members of the Group:
Not Applicable
Item 9 Notice of Dissolution of Group:
Not Applicable
Item 10 Certification:
By signing below the signatory certifies that, to the best of his knowledge
and belief, the securities referred to above were not acquired and are not held
for the purpose of or with the effect of changing or influencing the control of
the issuer of the securities and were not acquired and are not held in
connection with or as a participant in any transaction having that purpose or
effect.
Page 8 of 9
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: August 14, 2009
S.A.C. CAPITAL ADVISORS, L.P.
By: /s/ Peter Nussbaum
-----------------------------------------
Name: Peter Nussbaum
Title: Authorized Person
|
S.A.C. CAPITAL ADVISORS, INC.
By: /s/ Peter Nussbaum
-----------------------------------------
Name: Peter Nussbaum
Title: Authorized Person
|
CR INTRINSIC INVESTORS, LLC
By: /s/ Peter Nussbaum
-----------------------------------------
Name: Peter Nussbaum
Title: Authorized Person
|
STEVEN A. COHEN
By: /s/ Peter Nussbaum
-----------------------------------------
Name: Peter Nussbaum
Title: Authorized Person
|
Page 9 of 9
Allos Therapeutics, Inc. (MM) (NASDAQ:ALTH)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Allos Therapeutics, Inc. (MM) (NASDAQ:ALTH)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024